Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) — Stock Price

Rs156.17 INR
▼ -0.96% today

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) is currently trading at Rs156.17 INR, down 0.96% today. Over the past 52 weeks, shares have ranged between Rs129.02 and Rs196.01. This page tracks Nath Bio-Genes (India) Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Nath Bio-Genes (India) Limited market cap and net worth.

Nath Bio-Genes (India) Limited (NATHBIOGEN) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Nath Bio-Genes (India) Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Nath Bio-Genes (India) Limited Income Statement — Revenue, Profit & Earnings by Year

Nath Bio-Genes (India) Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs4.45 Billion Rs3.65 Billion Rs2.48 Billion Rs3.01 Billion Rs2.78 Billion
Cost of Revenue Rs2.41 Billion Rs1.36 Billion Rs1.44 Billion Rs1.35 Billion Rs1.24 Billion
Gross Profit Rs2.04 Billion Rs2.29 Billion Rs1.03 Billion Rs1.67 Billion Rs1.54 Billion
Research & Development — Rs124.17 Million Rs112.76 Million Rs93.71 Million Rs88.85 Million
SG&A Rs1.22 Billion Rs325.04 Million Rs72.86 Million Rs56.80 Million Rs66.01 Million
Total Operating Expenses Rs1.55 Billion Rs1.83 Billion Rs554.12 Million Rs466.19 Million Rs1.20 Billion
Operating Income Rs484.75 Million Rs459.82 Million Rs477.02 Million Rs1.73 Billion Rs1.38 Billion
EBITDA Rs524.39 Million Rs497.98 Million Rs536.39 Million Rs488.91 Million Rs-497.06 Million
EBIT Rs484.75 Million Rs459.82 Million Rs503.78 Million Rs458.79 Million Rs-527.90 Million
Interest Expense Rs159.88 Million Rs104.84 Million Rs88.13 Million Rs102.14 Million Rs106.44 Million
Income Before Tax Rs463.04 Million Rs400.44 Million Rs415.65 Million Rs363.18 Million Rs-633.90 Million
Income Tax Expense Rs46.73 Million Rs19.85 Million Rs19.46 Million Rs11.53 Million Rs39.52 Million
Net Income Rs416.30 Million Rs386.00 Million Rs396.19 Million Rs350.11 Million Rs-673.38 Million

Nath Bio-Genes (India) Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Nath Bio-Genes (India) Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs10.97 Billion Rs10.26 Billion Rs8.80 Billion Rs7.93 Billion Rs7.42 Billion
Total Current Assets Rs7.79 Billion Rs6.90 Billion Rs5.72 Billion Rs5.21 Billion Rs4.68 Billion
Cash & Equivalents — Rs870.50 Million Rs740.10 Million Rs49.00K Rs50.00K
Short-term Investments Rs1.63 Billion Rs59.00K Rs47.00K Rs50.00K Rs152.00K
Net Receivables Rs854.15 Million Rs889.01 Million Rs943.09 Million Rs973.27 Million Rs855.95 Million
Inventory Rs4.51 Billion Rs3.38 Billion Rs2.30 Billion Rs2.08 Billion Rs2.20 Billion
Property, Plant & Equipment — Rs2.43 Billion Rs2.41 Billion Rs2.34 Billion Rs2.33 Billion
Goodwill — — — — —
Total Liabilities Rs4.17 Billion Rs3.82 Billion Rs2.70 Billion Rs2.20 Billion Rs2.00 Billion
Total Current Liabilities Rs3.95 Billion Rs3.65 Billion Rs2.62 Billion Rs2.16 Billion Rs1.94 Billion
Long-term Debt Rs173.22 Million Rs129.76 Million Rs48.65 Million Rs4.03 Million Rs6.65 Million
Net Debt Rs625.06 Million Rs336.01 Million Rs329.41 Million Rs672.17 Million Rs887.91 Million
Total Stockholder Equity Rs6.80 Billion Rs6.44 Billion Rs6.10 Billion Rs5.73 Billion Rs5.42 Billion
Retained Earnings — Rs4.76 Billion Rs4.41 Billion Rs4.06 Billion Rs3.74 Billion

Nath Bio-Genes (India) Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Nath Bio-Genes (India) Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs-220.35 Million Rs175.81 Million Rs614.80 Million Rs383.67 Million Rs170.46 Million
Capital Expenditures Rs30.05 Million Rs79.20 Million Rs83.93 Million Rs25.49 Million Rs210.17 Million
Free Cash Flow Rs-250.40 Million Rs96.61 Million Rs530.87 Million Rs358.18 Million Rs-39.70 Million
Investing Cash Flow Rs-30.69 Million Rs-39.62 Million Rs-274.01 Million Rs-28.81 Million Rs-198.66 Million
Financing Cash Flow Rs122.00 Million Rs-21.30 Million Rs-45.67 Million Rs-16.68 Million Rs-222.27 Million
Dividends Paid Rs38.01 Million Rs38.01 Million Rs38.01 Million Rs38.01 Million Rs38.01 Million
Stock-Based Compensation — — — — —
Depreciation Rs39.64 Million Rs38.16 Million Rs32.61 Million Rs30.12 Million Rs30.84 Million
Change in Cash Rs-128.98 Million Rs114.89 Million Rs394.19 Million Rs338.15 Million Rs-250.48 Million

Nath Bio-Genes (India) Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Nath Bio-Genes (India) Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 27, 2026 — — —
Jan 21, 2026 — — —
Oct 21, 2025 — — —
Aug 05, 2025 — — —
Apr 29, 2025 — — —
Jan 16, 2025 — — —
Nov 07, 2020 1.59 3.78 -57.94%
Jun 30, 2020 21.71 14.19 +53.00%